The Decade of Biotech Has Begun
Legendary Stock Picker Shares Huge Prediction With Renowned Hedge Fund Manager
Published 1 Day Ago
Dr. Steve Sjuggerud may be one of the most well-known investors in the world…
For twenty years, he's gained national attention for his spot-on market calls. He predicted DOW 20,000, the dot-com crash, and the 2020 housing bubble.
10 years ago, when millionaire early stage investor Matt McCall shared some of his first recommendations with the public, live on air, the anchors laughed in his face. Yet FIVE of the stocks he named that day went on to soar over 1,000%.
With EIGHTEEN 1,000%+ all-time high recommendations made, McCall has built one of the greatest track records in the financial world.
So when Dr. Sjuggerud and Matt team up to issue a new prediction, you should listen. This could have an enormous impact on your wealth.
It involves the one sector that actually saw EVEN bigger gains than the tech sector during the dotcom boom... BIOTECH.
Not surprising, considering some of the biggest all-time high wins of Matt’s entire track record have been in biotech.
Allergan, up as high as 1,051%, Insulet, 1,411%, Dexcom over 3,400% – the list goes on and on.
You’re not going to see the details of what he’s predicting ANYWHERE in the news.
Stay tuned just a bit longer and you'll learn the name and ticker symbol of a single stock that he predicts will be a GAMECHANGER in the biotech space.
*Past performance does not guarantee future results. All investing involves the risk of loss.